Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How did you even arrive at that conclusion?
You guys are quiet haha - spread tightened up a bit and bigger bids coming in. Looking good
You guys are quiet haha - spread tightened up a bit and bigger bids coming in. Looking good
Time for the desperate folk who did not get in at 2s/3s to start walking this up before the hearing - the sellers are drying up. EDXC
The change in bid behavior is apparent - looking strong. Edxc
Locked down here - people need to hit the ask to get filled. Super thin... Lets move this up to double digits
Usually deals like this are formed for mutually beneficial reasons - does it matter at this point? We've seen the best performance we've had since a year ago, lets look forward. Edxc
Doesn't really matter either way. This is an all boats rise sort of scenario now. Better off
I think you've just had bad experiences in this sector then. There are certainly companies which are pennies and legitimate, I mean the Russel microcap index has pennies in it. You need to consider the form and function of these plays - EDXC is not diluted, has been beat up over the last few months and had established connections with companies who have enjoyed great success. If one were to sieve through the noise of this sector I feel that edxc would be one of the best fits for this form.
By that logic nearly every play on the sector is a pump and dump.. I swear people develop selective vision when comparing their portfolios.
I hope that some people get satisfaction over the fact one cannot lose 100% of anything unless it goes to 0... tidbit for the quantitative folk around here.
Are you entirely ignorant to the entire sector - or pennies in general? The whole sector has made a nose dive... You can load now and count on a push in the coming months or you can not and watch as those who loaded here make money.
This is like last year all over again.. The board content, the mm behavior, the bottoming out, and the sluggish pre-announcement volume. Time to buy heavy
Here is a similar spreadsheet from competitors so we can compare:
Period Ending Jun 30, 2014 Jun 30, 2013 Jun 30, 2012 Jun 30, 2011
Total Revenue 314 49 21 8
Cost of Revenue 163 - - -
Gross Profit 151 49 21 8
Operating Expenses
Research and Development 74 - - -
Sales, General and Admin. 1,687 523 565 499
Non-Recurring Items 172 179 207 147
Other 129 33 24 -
Operating Income (1,911) (687) (774) (638)
Income From Continuing Operations
Add'l Income/Expense Items - - (232) (430)
Earnings Before Interest and Tax (1,911) (687) (1,006) (1,068)
Interest Expense 94 79 132 116
Earnings Before Tax (2,005) (766) (1,138) (1,184)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,005) (766) (1,138) (1,184)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,005) (766) (1,138) (1,184)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,005) (766) (1,138) (1,184)
Here is a nice overview.
You hit the nail on the head... don't compare apples and oranges. Obviously a lower A/S is preferable but you need to put this in the sector average. Numerical facts are so often abused.. I have statistician colleagues who have written whole books on examples of this. The issue lies in the fact that we must homogenize to data before examining it. If you tell us that something costs $100 then it is entirely meaningless unless we have an average to test against. As this pertains to EDXC, we must be careful not to confuse raw data with information. There is a HUGE difference. Again, see my earlier post - I have homogenized the data so we are just looking at apples (or oranges if you prefer). This gives a realistic and unbiased estimate of the differences between EDXC and the competitors.
See the difference here is that what you are saying is entirely unsubstantiated and EDXC lacks the share structure to support such a scheme. Truthfully, with 90% of otc tickers you need to ask that question; however, an examination of the share structure is usually the tell... EDXC does not fit this model. On the other hand, the competition's share structure, with over 80% of shares on the open market can support such a scheme. Especially, at the inflated market cap that they possess.
Moreover, competition has been engaging in joint-ventures with other OTC companies with similar histories of dilution whereas EDXC has informed us of ventures with NASDAQ tickers such as Vuzix.
Please advise on how this is true.. If we just look at facts one can see by my earlier post that the competition had a market cap weighted revenue of -5% where as EDXC (while still negative) held this to -1%. Now in that time frame EDXCs share structure remained nearly identical with float/shares outstanding coming in less than 50% whereas the competition has over 80& on the open market. This is not only a show of lack of confidence by the competitions owners but also a testament to dilutive practices. EDXC
I decided to do a quick run over EDXC's numbers vs. similar competitors. I picked these metrics because they are homogeneous allowing us to compare. Some interesting results:
1. EDXC's float as a percentage of outstanding shares is: 49.7% compared to 81.9% for competitors.
2. EDXC's 2014 Q4 Net Revenue as a percentage of market value was: -1.55% compared to -5.6% for competitors.
3. EDXC's 2013 Q4 Net Revenue as a percentage of market value was: +2.11% compared to -0.8% for competitors.
As one can see, EDXC has outperformed competitors each of the quarters while maintaining a strong share structure. On the other hand, competitors have failed to post revenues for each of the quarters while the float grows. While the numbers today are admittedly underwhelming, these matters must be put in to tangible, quantitative terms.
Very happy to see that the share structure has remained intact while building business relations and reaching out to legitimate sources of future income. Very interesting fact: the ratio of authorized shares to total market value of EDXC is .125 whereas the same metric for competitors is .008529.
I think its just weak hands - this stock is heavily divided between short term shareholders and investors. There are catalysts coming and the former group is giving up shares to the latter. Essentially leaving money on the table. EDXC
Wait for the Q and rescheduling. This thing will fly. Edxc
There isn't a single potential stream of revenue that is contingent upon the success of cen biotech hence this a moot point. And furthermore, I think you are misappropriating your usage of "partner".
Endexx Corporation to Present at Cannabis Investor Webcast
Jan 28, 2015 (ACCESSWIRE via COMTEX) -- Cave Creek, AZ / ACCESSWIRE / January 28, 2015 / Endexx Corporation (OTC:EDXC) is a micro-cap publicly traded company, collaborating with independent software developers, scientists, engineers, and other companies to build businesses. Endexx Corporation, will be a presenter at the upcoming Cannabis Investor Webcast on Thursday, January 29, 2015 at 3:00 PM EST.
"We're excited that Endexx Corporation has decided to present to our online audience of industry investors, analysts, executives, media, and consumers," said Derwin A. Wallace, Senior VP of Investor Webcast. "The online interactive webcast will assist Endexx Corporation in increasing its awareness and exposure."
The Cannabis Investor Webcast will include presentations from privately-held and publicly-traded industry companies and professionals. Endexx Corporation's presentation will be 30-minutes long and followed by 15-minutes of Q&A. The Cannabis Investor Webcast is a great opportunity for the audience to research industry companies without taking time-off from work, paying registration fees and incurring travel-related expenses.
"The Cannabis Investor Webcast is an online interactive platform that will assist us in updating the cannabis community about our accretive acquisitions and opportunities," states Todd Davis, CEO of Endexx Corporation.
Cannabis investors, analysts, executives, media, and consumers who would like to attend our free online webcast please click on the link http://www.cannawebcast.com/ and visit the Registration Page and to view the recording of the webcast please click on this link Cannabis Investor Webcast Recordings two weeks after the presentation.
Endexx Corporation to Present at Cannabis Investor Webcast
Jan 28, 2015 (ACCESSWIRE via COMTEX) -- Cave Creek, AZ / ACCESSWIRE / January 28, 2015 / Endexx Corporation (OTC:EDXC) is a micro-cap publicly traded company, collaborating with independent software developers, scientists, engineers, and other companies to build businesses. Endexx Corporation, will be a presenter at the upcoming Cannabis Investor Webcast on Thursday, January 29, 2015 at 3:00 PM EST.
"We're excited that Endexx Corporation has decided to present to our online audience of industry investors, analysts, executives, media, and consumers," said Derwin A. Wallace, Senior VP of Investor Webcast. "The online interactive webcast will assist Endexx Corporation in increasing its awareness and exposure."
The Cannabis Investor Webcast will include presentations from privately-held and publicly-traded industry companies and professionals. Endexx Corporation's presentation will be 30-minutes long and followed by 15-minutes of Q&A. The Cannabis Investor Webcast is a great opportunity for the audience to research industry companies without taking time-off from work, paying registration fees and incurring travel-related expenses.
"The Cannabis Investor Webcast is an online interactive platform that will assist us in updating the cannabis community about our accretive acquisitions and opportunities," states Todd Davis, CEO of Endexx Corporation.
Cannabis investors, analysts, executives, media, and consumers who would like to attend our free online webcast please click on the link http://www.cannawebcast.com/ and visit the Registration Page and to view the recording of the webcast please click on this link Cannabis Investor Webcast Recordings two weeks after the presentation.
http://blogs.wsj.com/pharmalot/2015/01/26/pediatricians-urge-dea-to-reclassify-medical-marijuana-to-boost-research/
Groups of influence getting on board.
If you're at all familiar with these matters then you certainly know this is by no means a paradigm shift from Holder. The DEA never supported legalization either. This does not matter since they do not seem to have any intention on interfering on a state level - this is where the money will be made as it is unlikely that certain ultra-conservative states (i.e. the south) will be as willing to adopt legalization like the east and west coast will ultimately do. Moreover, this does not change the push towards full scale rescheduling Also, people will lobby for this, see here: http://www.huffingtonpost.com/2015/01/26/pediatricians-call-on-dea_n_6550486.html ... this is not some group of hippies - they are medical professionals wielding great wealth and influence. This all being said, hand picking a paragraph/comment made by the attorney general nominee does not show any long term potential impact on the sector.
I agree. Although seemingly unimportant - being on the breakout boards on Ihub is actually very useful. It only takes a relatively small amount of cash inflow to spike the volume and get some interest here. I think we're lucky we've been able to quietly accumulate shares. Should see some big news hitting soon - both for the sector and EDXC. Hang tight and don't let the fear mongers shake down your shares. EDXC
You PMed me? I cant reply privately due to membership.
If only you could call them like that...
Ah that makes sense - post tickers which are for preferred shares of multi-billion dollar companies... Bristol Myers Squibb has a market cap of 103+ billion. Clearly, in the same category as ACGX. Moreover, you're not even comparing the same type of product...
And this low volume is completely fine - all it takes is one good report to put it on the map while those who are in it now can quietly accumulate at these lows. Trust me, the transition from secret to hot is quick in this market. Hang tight, accumulate, let ACGX continue to show revenues, and watch for returns.
The current pps is a product of a small company making its way up. To have a place of business and a real line of work is unfortunately a rarity in the OTC, let alone having significant revenues. This might be the most undervalued ticker I own. We will see a push as revenues continue to come in. Some plays are hype plays, some are sector driven, this one seems to have what it takes to move on its own... Patience will pay off in my opinion.
I'm glad this held it's ground today. It's not common for a ticker on the pink sheets to have legitimate revenue streams... I believe this will do well. Also, the selling today did not look like dilution to me - way too spread out. Looks thin after .0025.
Agreed. We should see the sellers starting to dry up and we'll bounce from these levels. The partnerships and variety that EDXC has developed should prove to be fruitful in the coming months/year. Moreover, the whole sector has been largely depressed and we should see an upswing coming soon. EDXC
How in the world would you know if its tax selling or not? It very well may be... No one will argue the chart, people who got in at the wrong time this year may have lost money and they very well might be selling. This is a common cycle on the OTC and you know that. We will see buying at these prices coming in to the new year and we will see the sector move as a whole. Edxc
Incredibly oversold. Look for strong market correction when the buyers come in for these prices.
I think you're 100% correct. This is a temporary condition
Why do you think the share structure is like this?